Adacel Intramuscular

Name: Adacel Intramuscular

Adacel side effects

Keep track of any and all side effects you have after receiving Adacel vaccine. If you ever need to receive a booster dose, you will need to tell your doctor if the previous shot caused any side effects.

You should not receive a booster vaccine if you had a life threatening allergic reaction after the first shot.

Becoming infected with diphtheria, pertussis, or tetanus is much more dangerous to your health than receiving this vaccine. However, like any medicine, Adacel vaccine can cause side effects but the risk of serious side effects is extremely low.

Get emergency medical help if you have signs of an allergic reaction to Adacel: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have any of these side effects within 7 days after receiving Adacel:

  • numbness, weakness, or tingling in your feet and legs;

  • problems with walking or coordination;

  • sudden pain in your arms or shoulders;

  • a light-headed feeling, like you might pass out;

  • vision problems, ringing in your ears;

  • seizure (black-out or convulsions); or

  • redness, swelling, bleeding, or severe pain where the shot was given.

Common Adacel side effects may include:

  • mild pain or tenderness where the shot was given;

  • headache or tiredness;

  • body aches; or

  • mild nausea, diarrhea, or vomiting.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1-800-822-7967.

Usual Pediatric Dose for Tetanus Prophylaxis

Booster Immunization (tetanus/diphtheria/pertussis, acel (Tdap) 5 units-2 units-15.5 mcg/0.5 mL ADACEL):

11 years or older: 0.5 mL IM once. Individuals who have completed a primary series against tetanus and who sustain wounds which are minor and uncomplicated, should receive a booster dose of a tetanus toxoid containing vaccine only if they have not received a tetanus toxoid within the preceding 10 years. For tetanus prone wounds, a booster is appropriate if the patient has not received a tetanus toxoid containing preparation within the preceding 5 years.

Booster Immunization (tetanus/diphtheria/pertussis, acel (Tdap) 5 units-2 .5units-18.5 mcg/0.5 mL BOOSTRIX):

10 years or older: 0.5 mL IM once. Individuals who have completed a primary series against tetanus and who sustain wounds which are minor and uncomplicated, should receive a booster dose of a tetanus toxoid containing vaccine only if they have not received a tetanus toxoid within the preceding 10 years. For tetanus prone wounds, a booster is appropriate if the patient has not received a tetanus toxoid containing preparation within the preceding 5 years.

Dialysis

Data not available

Diphtheria toxoid / pertussis, acellular / tetanus toxoid Pregnancy Warnings

Diphtheria/pertussis, acellular/tetanus has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of adverse effects on embryo-fetal development. There are no controlled data in human pregnancy. Diphtheria/pertussis, acellular/tetanus is only recommended for use during pregnancy when benefit outweighs risk.

A BOOSTRIX Pregnancy Registry has been established to monitor maternal-fetal outcome of vaccine exposures during pregnancy. To register patients, physicians may call 888-452-9622 (USA).

(web3)